News | May 15, 2023
Briefs: Dr. Reddy's Laboratories and Max Healthcare Institute
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
Apollo continues to invest in genomics technology and research for better patient care
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
Following successful completion of full set of clinical studies of proposed rituximab biosimilar candidate DRL_RI, Dr. Reddy’s will now prepare to file in the United States, European Union and other regions
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
He urged the dignitaries to collaboratively work on the identified domains of improvement and make detailed reports on them
Subscribe To Our Newsletter & Stay Updated
